Scientists build giant DNA library to crack ataxia mysteries
NCT ID NCT04529252
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study from Mayo Clinic is creating a large collection of blood, urine, stool, spinal fluid, and skin samples from 1000 people with ataxia and related genetic diseases, plus their healthy family members. The goal is to better understand the genetic and physical features of these conditions. No treatments are being tested, but the repository may help future research.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help researchers better understand the genetic causes and progression of ataxia and related diseases, potentially pointing toward future treatments.
- What could go wrong
- This is an observational study, not a treatment trial. It only collects samples and data, so it won't directly help participants. Results may take years to yield meaningful insights.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBELLAR ATAXIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Florida
Jacksonville, Florida, 32224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a brain ZAP and rehab combo ease movement problems?
- New study tests workplace coaching to keep Parkinson's patients on the job
- Robot suit helps stroke and spinal injury patients walk again – small study shows promise
- New hope for SCA patients: expanded access to investigational drug troriluzole
- Could a drug slow rare brain disease? new study uses Real-World data to find out
- Ultrasound may spot rare nerve disease CANVAS